Showing results (351-360 of 365) with videos related to

Sort By:
Pageof 37
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 28, 2023
Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) studyA Bayle, L Belcaid, M Aldea, et al.
EMBO Reports|February 22, 2019
HRAS-driven cancer cells are vulnerable to TRPML1 inhibitionJewon Jung, Kwang-Jin Cho, Ali K Naji, et al.
Virchows Archiv : an International Journal of Pathology|February 8, 2019
National multicentric evaluation of quality of pathology reports for rectal cancer in France in 2016C Boutanos, M Capdepont, M Svrcek, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Codon-specific KRAS mutations predict survival in advanced pancreatic cancerA Boilève, A Rousseau, M Hilmi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2019
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registryJ Mazieres, A Drilon, A Lusque, et al.
Journal Francais D'Ophtalmologie|December 19, 2024
[Cataract surgery training in France: Analysis of the results of the European Board of Ophthalmology survey in the French cohort]R Yaïci, M Sanogo, F Lefebvre, et al.
Journal of Medical Genetics|March 18, 2009
Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disordersS Ben-Shachar, B Lanpher, J R German, et al.
The Review of Scientific Instruments|April 3, 2016
First set of gated x-ray imaging diagnostics for the Laser Megajoule facilityR Rosch, C Trosseille, T Caillaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2026
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted TherapiesM Aldea, S Lenahan, M-A Locquet, et al.
Plos One|January 28, 2017
A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib MalateAlice C O'Farrell, Rhys Evans, Johanna M U Silvola, et al.
Pageof 37